TRT for under $100/month: what the pitch leaves out

What did @socalurologyinstitute actually say?

Dr. Gary Bellman, a urologist, pitched a virtual TRT service charging "$250 for a quarter" with four annual visits, totaling $1,000 per year out of pocket. He says testosterone prescriptions and blood tests can go through your insurance, and that cash-pay testosterone injections are "quite cheap" if you're uninsured. The TikTok caption says "less than $100/month," which is technically consistent with the quarterly math but rounds down conveniently.

He's not claiming a cure. He's not promising outcomes. He's doing something more straightforward: marketing his telehealth urology practice to men who feel underserved by their current providers. That framing, "your doctor doesn't want to prescribe it or they're giving you bad advice," is doing real work here. It positions existing physicians as obstacles rather than safeguards, which deserves scrutiny even when the underlying service may be legitimate.

Does the science back this up?

The clinical case for TRT in men with confirmed hypogonadism is solid. Where things get slippery is the "hormone optimization" framing implied by hashtags like "antiaging" and "trttransformation."

The 2023 TRAVERSE trial (Lincoff et al., New England Journal of Medicine) is the biggest cardiovascular safety data point we now have on TRT. It found no significant increase in major adverse cardiovascular events in men with hypogonadism and pre-existing cardiovascular risk, which was genuinely reassuring. But TRAVERSE enrolled men with confirmed low testosterone and symptoms, not men chasing optimization. The FDA indication remains treatment of hypogonadism, not aging-related testosterone decline in otherwise healthy men.

On the telehealth delivery model itself, a 2022 study by Gabrielson et al. in Urology found that telemedicine TRT prescribing increased substantially post-pandemic, with comparable short-term outcomes to in-person care, though the authors flagged concerns about adequate baseline workup being skipped. Four virtual visits per year is on the lower end of monitoring frequency recommended by the Endocrine Society's 2018 clinical practice guidelines, which suggest symptom and lab review every 3-6 months initially.

What did they get wrong (or right)?

Credit where it's due: the pricing structure is transparent. Bellman spells out the quarterly fee clearly and acknowledges that testosterone injections are inexpensive generically. Testosterone cypionate, the most commonly prescribed injectable, typically costs $30-$80 per month without insurance at major pharmacies. That part checks out.

What he glosses over is the baseline evaluation. Proper TRT initiation requires at minimum two morning total testosterone measurements, LH, FSH, prolactin, hematocrit, and PSA screening in older men, per Endocrine Society guidelines. None of that workup is mentioned. The implicit message is "come to us if your doctor won't prescribe it," but sometimes a doctor not prescribing TRT is the correct clinical call, not a knowledge gap.

The hashtag "hcg" is also worth flagging. HCG (human chorionic gonadotropin) is used alongside TRT to preserve fertility and testicular volume, but since the FDA's 2020 compounding policy changes, access has become complicated. Compounded HCG is not equivalent to FDA-approved Pregnyl or Novarel. That distinction matters clinically and legally, and the video says nothing about it.

What should you actually know?

Telehealth TRT can be a legitimate and accessible option, but the framing of "your doctor won't prescribe it" as a red flag deserves pushback. Physicians decline TRT requests for real reasons: uncontrolled polycythemia, active prostate cancer concerns, desire for fertility, or simply testosterone levels that aren't actually low by any validated threshold.

Before signing up for any telehealth TRT service, including this one, confirm they will run a full baseline panel (two morning testosterone draws, LH, FSH, CBC, PSA if you're over 40), that they monitor hematocrit every 3-6 months initially per Endocrine Society 2018 guidelines, and that they have a plan for managing side effects like erythrocytosis or infertility concerns. A provider who charges $1,000 a year and accepts insurance for labs can absolutely meet those standards. But four virtual visits alone does not guarantee they will.

The $250/quarter fee is fair by current telehealth market standards. Hims, Maximus, and similar platforms charge comparable or higher amounts. That doesn't mean every man who calls this office needs TRT. It means the price point isn't the problem to interrogate here. The clinical thoroughness is.